Effects of antidepressant treatment on heart rate variability in major depression: A quantitative review

被引：101
作者：
van Zyl L.T. [1 ]
Hasegawa T. [1 ,2 ]
Nagata K. [2 ]
机构：
[1] Department of Psychiatry, Division of Psychosomatic Medicine and Consultation-Liaison Psychiatry, Queen's University, Kingston
[2] Hamamatsu University, School of Medicine, Hamamatsu City 431-3192
来源：
BioPsychoSocial Medicine | / 2卷 / 1期
关键词：
Heart Rate Variability; Major Depressive Disorder; Bupropion; Mirtazapine; Reboxetine;
D O I：
10.1186/1751-0759-2-12
中图分类号：
学科分类号：
摘要：
Background: The literature measuring effects of antidepressant and electroconvulsive therapy (ECT) for major depression on heart rate variability (HRV) in medically well individuals was reviewed. Methods: Fourteen studies evaluating HRV were included. Twenty three pre-post or within group comparisons were available. Treatment impact on measures of HRV was pooled over studies. We examined different classes of antidepressants, and for short and long electrocardiogram (ECG) recordings separately. Results: Tricyclic antidepressants (TCAs) were associated with declines in most measures of HRV and significant increase in heart rate (HR) in studies with short recording intervals. No significant changes were found for longer recording times. Treatment effects with selective serotonin reuptake inhibitors (SSRIs) were more variable. Short-recording studies revealed a significant decrease in HR and an increase in one HRV measure. In two 24-hour recording studies no significant changes were observed. No relationship between ECT and HRV has been established in the literature. The effects of other drugs are reported. Limitations: Few studies measure the effects of treatment of depression on HRV. Existing studies have generally used very small samples, employing a variety of measurements and methodologies. Conclusion: We confirm that TCAs are associated with a large decrease in HRV and increase HR. However, data for SSRIs is not clear. Although the effect of SSRIs on HRV is weaker than for TCAs, evidence shows that SSRIs are associated with a small decrease in HR, and an increase in one measure of HRV. The use of TCAs in depression leads to changes in HRV that are associated with increased risk of mortality. © 2008 van Zyl et al; licensee BioMed Central Ltd.
引用
收藏
相关论文
共 63 条
[1]  
Kleiger R.E., Miller J.P., Bigger Jr. J.T., Moss A.J., Decreased heart rate variability and its association with increased mortality after acute myocardial infarction, Am J Cardiol, 59, pp. 256-262, (1987)
[2]  
La Rovere M.T., Bigger Jr. J.T., Marcus F.I., Mortara A., Schwartz P.J., Baroreflex sensitivity and heart-rate variability in prediction of total cardiac mortality after myocardial infarction. ATRAMI (Autonomic Tone and Reflexes After Myocardial Infarction) Investigators, Lancet, 351, pp. 478-484, (1998)
[3]  
Lombardi F., Sandrone G., Pernpruner S., Sala R., Garimoldi M., Cerutti S., Baselli G., Pagani M., Malliani A., Heart rate variability as an index of sympathovagal interaction after acute myocardial infarction, Am J Cardiol, 60, pp. 1239-1245, (1987)
[4]  
Saul J.P., Arai Y., Berger R.D., Lilly L.S., Colucci W.S., Cohen R.J., Assessment of autonomic regulation in chronic congestive heart failure by heart rate spectral analysis2, Am J Cardiol, 61, pp. 1292-1299, (1988)
[5]  
Wolf M.M., Varigos G.A., Hunt D., Sloman J.G., Sinus arrhythmia in acute myocardial infarction2, Med J Aust, 2, pp. 52-53, (1978)
[6]  
Agelink M.W., Boz C., Ullrich H., Andrich J., Relationship between major depression and heart rate variability. Clinical consequences and implications for antidepressive treatment, Psychiatry Research, 113, pp. 139-149, (2002)
[7]  
Nahshoni E., Aravot D., Aizenberg D., Sigler M., Zalsman G., Strasberg B., Imbar S., Adler E., Weizman A., Heart rate variability in patients with major depression, Psychosomatics, 45, pp. 129-134, (2004)
[8]  
Rechlin T., Weis M., Spitzer A., Kaschka W.P., Are affective disorders associated with alterations of heart rate variability?, Journal of Affective Disorders, 32, pp. 271-275, (1994)
[9]  
Tulen J.H., Bruijn J.A., de Man K.J., Pepplinkhuizen L., van den Meiracker A.H., Cardiovascular variability in major depressive disorder and effects of imipramine or mirtazapine, J Clin Psychopharmacol, 16, pp. 135-145, (1996)
[10]  
Lett H.S., Blumenthal J.A., Babyak M.A., Sherwood A., Strauman T., Robins C., Newman M.F., Depression as a risk factor for coronary artery disease: Evidence, mechanisms, and treatment, Psychosomatic Medicine, 66, pp. 305-315, (2004)
1234567